nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—Nucleoside Analog—Azathioprine—systemic scleroderma	0.517	1	CiPCiCtD
Ribavirin—IMPDH1—Mycophenolic acid—systemic scleroderma	0.234	0.641	CbGbCtD
Ribavirin—IMPDH1—Mycophenolate mofetil—systemic scleroderma	0.131	0.358	CbGbCtD
Ribavirin—ENPP1—connective tissue—systemic scleroderma	0.00164	0.0956	CbGeAlD
Ribavirin—ENPP1—skin of body—systemic scleroderma	0.00148	0.0863	CbGeAlD
Ribavirin—ENPP1—tendon—systemic scleroderma	0.00113	0.0657	CbGeAlD
Ribavirin—NT5C2—smooth muscle tissue—systemic scleroderma	0.0011	0.0639	CbGeAlD
Ribavirin—SLC28A3—digestive system—systemic scleroderma	0.00104	0.0606	CbGeAlD
Ribavirin—ENPP1—lung—systemic scleroderma	0.00099	0.0577	CbGeAlD
Ribavirin—IMPDH1—smooth muscle tissue—systemic scleroderma	0.00089	0.0519	CbGeAlD
Ribavirin—SLC28A3—lung—systemic scleroderma	0.000869	0.0506	CbGeAlD
Ribavirin—NT5C2—digestive system—systemic scleroderma	0.000866	0.0505	CbGeAlD
Ribavirin—NT5C2—tendon—systemic scleroderma	0.000824	0.048	CbGeAlD
Ribavirin—Glucosamine—MMP9—systemic scleroderma	0.000782	1	CrCbGaD
Ribavirin—NT5C2—lung—systemic scleroderma	0.000723	0.0421	CbGeAlD
Ribavirin—ADK—smooth muscle tissue—systemic scleroderma	0.000702	0.0409	CbGeAlD
Ribavirin—ADK—skin of body—systemic scleroderma	0.000693	0.0404	CbGeAlD
Ribavirin—IMPDH1—tendon—systemic scleroderma	0.000669	0.039	CbGeAlD
Ribavirin—SLC29A1—connective tissue—systemic scleroderma	0.000653	0.0381	CbGeAlD
Ribavirin—IMPDH1—lung—systemic scleroderma	0.000587	0.0342	CbGeAlD
Ribavirin—ADK—tendon—systemic scleroderma	0.000527	0.0307	CbGeAlD
Ribavirin—ENPP1—Betamethasone—Mometasone—systemic scleroderma	0.000486	0.324	CbGdCrCtD
Ribavirin—ENPP1—Dexamethasone—Mometasone—systemic scleroderma	0.000486	0.324	CbGdCrCtD
Ribavirin—SLC29A1—digestive system—systemic scleroderma	0.000472	0.0275	CbGeAlD
Ribavirin—ADK—lung—systemic scleroderma	0.000463	0.027	CbGeAlD
Ribavirin—SLC29A1—tendon—systemic scleroderma	0.000449	0.0262	CbGeAlD
Ribavirin—SLC29A1—lung—systemic scleroderma	0.000394	0.023	CbGeAlD
Ribavirin—ENPP1—Dexamethasone—Prednisone—systemic scleroderma	0.000265	0.176	CbGdCrCtD
Ribavirin—ENPP1—Betamethasone—Prednisone—systemic scleroderma	0.000265	0.176	CbGdCrCtD
Ribavirin—Myalgia—Mycophenolate mofetil—systemic scleroderma	3.16e-05	0.00032	CcSEcCtD
Ribavirin—Myocardial infarction—Prednisone—systemic scleroderma	3.16e-05	0.00032	CcSEcCtD
Ribavirin—Neuropathy peripheral—Prednisone—systemic scleroderma	3.16e-05	0.00032	CcSEcCtD
Ribavirin—Breast disorder—Methotrexate—systemic scleroderma	3.16e-05	0.000319	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	3.15e-05	0.000319	CcSEcCtD
Ribavirin—Anxiety—Mycophenolate mofetil—systemic scleroderma	3.15e-05	0.000319	CcSEcCtD
Ribavirin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	3.15e-05	0.000318	CcSEcCtD
Ribavirin—Hypersensitivity—Azathioprine—systemic scleroderma	3.14e-05	0.000318	CcSEcCtD
Ribavirin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	3.14e-05	0.000318	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	3.14e-05	0.000318	CcSEcCtD
Ribavirin—Insomnia—Lisinopril—systemic scleroderma	3.13e-05	0.000317	CcSEcCtD
Ribavirin—Discomfort—Mycophenolate mofetil—systemic scleroderma	3.13e-05	0.000316	CcSEcCtD
Ribavirin—Paraesthesia—Lisinopril—systemic scleroderma	3.11e-05	0.000314	CcSEcCtD
Ribavirin—Vomiting—Captopril—systemic scleroderma	3.11e-05	0.000314	CcSEcCtD
Ribavirin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	3.09e-05	0.000313	CcSEcCtD
Ribavirin—Dyspnoea—Lisinopril—systemic scleroderma	3.09e-05	0.000312	CcSEcCtD
Ribavirin—Rash—Captopril—systemic scleroderma	3.08e-05	0.000312	CcSEcCtD
Ribavirin—Dermatitis—Captopril—systemic scleroderma	3.08e-05	0.000311	CcSEcCtD
Ribavirin—Somnolence—Lisinopril—systemic scleroderma	3.08e-05	0.000311	CcSEcCtD
Ribavirin—Headache—Captopril—systemic scleroderma	3.06e-05	0.00031	CcSEcCtD
Ribavirin—Confusional state—Mycophenolate mofetil—systemic scleroderma	3.06e-05	0.000309	CcSEcCtD
Ribavirin—Dyspepsia—Lisinopril—systemic scleroderma	3.05e-05	0.000308	CcSEcCtD
Ribavirin—Body temperature increased—Mycophenolic acid—systemic scleroderma	3.04e-05	0.000307	CcSEcCtD
Ribavirin—Abdominal pain—Mycophenolic acid—systemic scleroderma	3.04e-05	0.000307	CcSEcCtD
Ribavirin—Oedema—Mycophenolate mofetil—systemic scleroderma	3.03e-05	0.000307	CcSEcCtD
Ribavirin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	3.03e-05	0.000307	CcSEcCtD
Ribavirin—Asthma—Methotrexate—systemic scleroderma	3.02e-05	0.000306	CcSEcCtD
Ribavirin—Decreased appetite—Lisinopril—systemic scleroderma	3.01e-05	0.000304	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	2.99e-05	0.000302	CcSEcCtD
Ribavirin—Fatigue—Lisinopril—systemic scleroderma	2.98e-05	0.000302	CcSEcCtD
Ribavirin—Shock—Mycophenolate mofetil—systemic scleroderma	2.98e-05	0.000302	CcSEcCtD
Ribavirin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	2.97e-05	0.000301	CcSEcCtD
Ribavirin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	2.97e-05	0.0003	CcSEcCtD
Ribavirin—Hypersensitivity—Leflunomide—systemic scleroderma	2.97e-05	0.0003	CcSEcCtD
Ribavirin—Pancreatitis—Methotrexate—systemic scleroderma	2.96e-05	0.0003	CcSEcCtD
Ribavirin—Pain—Lisinopril—systemic scleroderma	2.96e-05	0.000299	CcSEcCtD
Ribavirin—Constipation—Lisinopril—systemic scleroderma	2.96e-05	0.000299	CcSEcCtD
Ribavirin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	2.96e-05	0.000299	CcSEcCtD
Ribavirin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	2.95e-05	0.000298	CcSEcCtD
Ribavirin—Bradycardia—Prednisone—systemic scleroderma	2.95e-05	0.000298	CcSEcCtD
Ribavirin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	2.93e-05	0.000296	CcSEcCtD
Ribavirin—Diarrhoea—Azathioprine—systemic scleroderma	2.92e-05	0.000295	CcSEcCtD
Ribavirin—Haemoglobin—Prednisone—systemic scleroderma	2.91e-05	0.000294	CcSEcCtD
Ribavirin—Nausea—Captopril—systemic scleroderma	2.9e-05	0.000294	CcSEcCtD
Ribavirin—Abdominal discomfort—Methotrexate—systemic scleroderma	2.9e-05	0.000293	CcSEcCtD
Ribavirin—Haemorrhage—Prednisone—systemic scleroderma	2.89e-05	0.000293	CcSEcCtD
Ribavirin—Anorexia—Mycophenolate mofetil—systemic scleroderma	2.89e-05	0.000292	CcSEcCtD
Ribavirin—Asthenia—Leflunomide—systemic scleroderma	2.89e-05	0.000292	CcSEcCtD
Ribavirin—Hallucination—Prednisone—systemic scleroderma	2.88e-05	0.000291	CcSEcCtD
Ribavirin—Feeling abnormal—Lisinopril—systemic scleroderma	2.85e-05	0.000288	CcSEcCtD
Ribavirin—Pruritus—Leflunomide—systemic scleroderma	2.85e-05	0.000288	CcSEcCtD
Ribavirin—Connective tissue disorder—Prednisone—systemic scleroderma	2.84e-05	0.000288	CcSEcCtD
Ribavirin—Hypotension—Mycophenolate mofetil—systemic scleroderma	2.83e-05	0.000287	CcSEcCtD
Ribavirin—Gastrointestinal pain—Lisinopril—systemic scleroderma	2.83e-05	0.000286	CcSEcCtD
Ribavirin—Neutropenia—Methotrexate—systemic scleroderma	2.83e-05	0.000286	CcSEcCtD
Ribavirin—Dizziness—Azathioprine—systemic scleroderma	2.82e-05	0.000285	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	2.81e-05	0.000284	CcSEcCtD
Ribavirin—Erectile dysfunction—Methotrexate—systemic scleroderma	2.78e-05	0.000281	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	2.76e-05	0.000279	CcSEcCtD
Ribavirin—Photosensitivity reaction—Methotrexate—systemic scleroderma	2.76e-05	0.000279	CcSEcCtD
Ribavirin—Asthenia—Mycophenolic acid—systemic scleroderma	2.76e-05	0.000279	CcSEcCtD
Ribavirin—Diarrhoea—Leflunomide—systemic scleroderma	2.76e-05	0.000279	CcSEcCtD
Ribavirin—Urticaria—Lisinopril—systemic scleroderma	2.75e-05	0.000278	CcSEcCtD
Ribavirin—Insomnia—Mycophenolate mofetil—systemic scleroderma	2.74e-05	0.000277	CcSEcCtD
Ribavirin—Abdominal pain—Lisinopril—systemic scleroderma	2.74e-05	0.000277	CcSEcCtD
Ribavirin—Body temperature increased—Lisinopril—systemic scleroderma	2.74e-05	0.000277	CcSEcCtD
Ribavirin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	2.72e-05	0.000275	CcSEcCtD
Ribavirin—Pruritus—Mycophenolic acid—systemic scleroderma	2.72e-05	0.000275	CcSEcCtD
Ribavirin—Vomiting—Azathioprine—systemic scleroderma	2.71e-05	0.000274	CcSEcCtD
Ribavirin—Pneumonia—Methotrexate—systemic scleroderma	2.71e-05	0.000274	CcSEcCtD
Ribavirin—Eye disorder—Prednisone—systemic scleroderma	2.7e-05	0.000273	CcSEcCtD
Ribavirin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	2.7e-05	0.000273	CcSEcCtD
Ribavirin—Somnolence—Mycophenolate mofetil—systemic scleroderma	2.7e-05	0.000273	CcSEcCtD
Ribavirin—Infestation NOS—Methotrexate—systemic scleroderma	2.69e-05	0.000272	CcSEcCtD
Ribavirin—Infestation—Methotrexate—systemic scleroderma	2.69e-05	0.000272	CcSEcCtD
Ribavirin—Rash—Azathioprine—systemic scleroderma	2.69e-05	0.000272	CcSEcCtD
Ribavirin—Dermatitis—Azathioprine—systemic scleroderma	2.69e-05	0.000272	CcSEcCtD
Ribavirin—Depression—Methotrexate—systemic scleroderma	2.69e-05	0.000272	CcSEcCtD
Ribavirin—Flushing—Prednisone—systemic scleroderma	2.69e-05	0.000272	CcSEcCtD
Ribavirin—Headache—Azathioprine—systemic scleroderma	2.67e-05	0.00027	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	2.67e-05	0.00027	CcSEcCtD
Ribavirin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	2.67e-05	0.00027	CcSEcCtD
Ribavirin—Dizziness—Leflunomide—systemic scleroderma	2.66e-05	0.000269	CcSEcCtD
Ribavirin—Renal failure—Methotrexate—systemic scleroderma	2.65e-05	0.000268	CcSEcCtD
Ribavirin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	2.64e-05	0.000267	CcSEcCtD
Ribavirin—Diarrhoea—Mycophenolic acid—systemic scleroderma	2.63e-05	0.000266	CcSEcCtD
Ribavirin—Stomatitis—Methotrexate—systemic scleroderma	2.63e-05	0.000266	CcSEcCtD
Ribavirin—Angiopathy—Prednisone—systemic scleroderma	2.63e-05	0.000265	CcSEcCtD
Ribavirin—Conjunctivitis—Methotrexate—systemic scleroderma	2.62e-05	0.000265	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	2.62e-05	0.000265	CcSEcCtD
Ribavirin—Immune system disorder—Prednisone—systemic scleroderma	2.61e-05	0.000264	CcSEcCtD
Ribavirin—Pain—Mycophenolate mofetil—systemic scleroderma	2.59e-05	0.000262	CcSEcCtD
Ribavirin—Constipation—Mycophenolate mofetil—systemic scleroderma	2.59e-05	0.000262	CcSEcCtD
Ribavirin—Arrhythmia—Prednisone—systemic scleroderma	2.59e-05	0.000261	CcSEcCtD
Ribavirin—Vomiting—Leflunomide—systemic scleroderma	2.56e-05	0.000259	CcSEcCtD
Ribavirin—Alopecia—Prednisone—systemic scleroderma	2.56e-05	0.000259	CcSEcCtD
Ribavirin—Hypersensitivity—Lisinopril—systemic scleroderma	2.55e-05	0.000258	CcSEcCtD
Ribavirin—Hepatobiliary disease—Methotrexate—systemic scleroderma	2.55e-05	0.000258	CcSEcCtD
Ribavirin—Dizziness—Mycophenolic acid—systemic scleroderma	2.54e-05	0.000257	CcSEcCtD
Ribavirin—Epistaxis—Methotrexate—systemic scleroderma	2.54e-05	0.000257	CcSEcCtD
Ribavirin—Rash—Leflunomide—systemic scleroderma	2.54e-05	0.000257	CcSEcCtD
Ribavirin—Dermatitis—Leflunomide—systemic scleroderma	2.54e-05	0.000257	CcSEcCtD
Ribavirin—Mental disorder—Prednisone—systemic scleroderma	2.54e-05	0.000256	CcSEcCtD
Ribavirin—Nausea—Azathioprine—systemic scleroderma	2.53e-05	0.000256	CcSEcCtD
Ribavirin—Headache—Leflunomide—systemic scleroderma	2.52e-05	0.000255	CcSEcCtD
Ribavirin—Erythema—Prednisone—systemic scleroderma	2.52e-05	0.000255	CcSEcCtD
Ribavirin—Malnutrition—Prednisone—systemic scleroderma	2.52e-05	0.000255	CcSEcCtD
Ribavirin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	2.5e-05	0.000253	CcSEcCtD
Ribavirin—Asthenia—Lisinopril—systemic scleroderma	2.48e-05	0.000251	CcSEcCtD
Ribavirin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	2.48e-05	0.000251	CcSEcCtD
Ribavirin—Pruritus—Lisinopril—systemic scleroderma	2.45e-05	0.000248	CcSEcCtD
Ribavirin—Vomiting—Mycophenolic acid—systemic scleroderma	2.44e-05	0.000247	CcSEcCtD
Ribavirin—Haemoglobin—Methotrexate—systemic scleroderma	2.43e-05	0.000246	CcSEcCtD
Ribavirin—Rash—Mycophenolic acid—systemic scleroderma	2.42e-05	0.000245	CcSEcCtD
Ribavirin—Dermatitis—Mycophenolic acid—systemic scleroderma	2.42e-05	0.000245	CcSEcCtD
Ribavirin—Haemorrhage—Methotrexate—systemic scleroderma	2.42e-05	0.000245	CcSEcCtD
Ribavirin—Hepatitis—Methotrexate—systemic scleroderma	2.42e-05	0.000245	CcSEcCtD
Ribavirin—Urticaria—Mycophenolate mofetil—systemic scleroderma	2.41e-05	0.000244	CcSEcCtD
Ribavirin—Headache—Mycophenolic acid—systemic scleroderma	2.41e-05	0.000243	CcSEcCtD
Ribavirin—Pharyngitis—Methotrexate—systemic scleroderma	2.4e-05	0.000243	CcSEcCtD
Ribavirin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	2.4e-05	0.000242	CcSEcCtD
Ribavirin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	2.4e-05	0.000242	CcSEcCtD
Ribavirin—Nausea—Leflunomide—systemic scleroderma	2.39e-05	0.000242	CcSEcCtD
Ribavirin—Urinary tract disorder—Methotrexate—systemic scleroderma	2.39e-05	0.000241	CcSEcCtD
Ribavirin—Vision blurred—Prednisone—systemic scleroderma	2.37e-05	0.00024	CcSEcCtD
Ribavirin—Urethral disorder—Methotrexate—systemic scleroderma	2.37e-05	0.00024	CcSEcCtD
Ribavirin—Diarrhoea—Lisinopril—systemic scleroderma	2.37e-05	0.000239	CcSEcCtD
Ribavirin—Ill-defined disorder—Prednisone—systemic scleroderma	2.34e-05	0.000236	CcSEcCtD
Ribavirin—Visual impairment—Methotrexate—systemic scleroderma	2.33e-05	0.000236	CcSEcCtD
Ribavirin—Anaemia—Prednisone—systemic scleroderma	2.33e-05	0.000235	CcSEcCtD
Ribavirin—Agitation—Prednisone—systemic scleroderma	2.32e-05	0.000234	CcSEcCtD
Ribavirin—Angioedema—Prednisone—systemic scleroderma	2.3e-05	0.000233	CcSEcCtD
Ribavirin—Dizziness—Lisinopril—systemic scleroderma	2.29e-05	0.000231	CcSEcCtD
Ribavirin—Erythema multiforme—Methotrexate—systemic scleroderma	2.29e-05	0.000231	CcSEcCtD
Ribavirin—Nausea—Mycophenolic acid—systemic scleroderma	2.28e-05	0.000231	CcSEcCtD
Ribavirin—Malaise—Prednisone—systemic scleroderma	2.27e-05	0.00023	CcSEcCtD
Ribavirin—Vertigo—Prednisone—systemic scleroderma	2.26e-05	0.000229	CcSEcCtD
Ribavirin—Eye disorder—Methotrexate—systemic scleroderma	2.26e-05	0.000229	CcSEcCtD
Ribavirin—Syncope—Prednisone—systemic scleroderma	2.26e-05	0.000228	CcSEcCtD
Ribavirin—Tinnitus—Methotrexate—systemic scleroderma	2.26e-05	0.000228	CcSEcCtD
Ribavirin—Cardiac disorder—Methotrexate—systemic scleroderma	2.24e-05	0.000227	CcSEcCtD
Ribavirin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	2.23e-05	0.000226	CcSEcCtD
Ribavirin—Loss of consciousness—Prednisone—systemic scleroderma	2.21e-05	0.000224	CcSEcCtD
Ribavirin—Vomiting—Lisinopril—systemic scleroderma	2.2e-05	0.000223	CcSEcCtD
Ribavirin—Angiopathy—Methotrexate—systemic scleroderma	2.19e-05	0.000222	CcSEcCtD
Ribavirin—Immune system disorder—Methotrexate—systemic scleroderma	2.18e-05	0.000221	CcSEcCtD
Ribavirin—Rash—Lisinopril—systemic scleroderma	2.18e-05	0.000221	CcSEcCtD
Ribavirin—Convulsion—Prednisone—systemic scleroderma	2.18e-05	0.000221	CcSEcCtD
Ribavirin—Dermatitis—Lisinopril—systemic scleroderma	2.18e-05	0.00022	CcSEcCtD
Ribavirin—Mediastinal disorder—Methotrexate—systemic scleroderma	2.18e-05	0.00022	CcSEcCtD
Ribavirin—Asthenia—Mycophenolate mofetil—systemic scleroderma	2.18e-05	0.00022	CcSEcCtD
Ribavirin—Hypertension—Prednisone—systemic scleroderma	2.18e-05	0.00022	CcSEcCtD
Ribavirin—Chills—Methotrexate—systemic scleroderma	2.17e-05	0.000219	CcSEcCtD
Ribavirin—Headache—Lisinopril—systemic scleroderma	2.17e-05	0.000219	CcSEcCtD
Ribavirin—Pruritus—Mycophenolate mofetil—systemic scleroderma	2.15e-05	0.000217	CcSEcCtD
Ribavirin—Arthralgia—Prednisone—systemic scleroderma	2.14e-05	0.000217	CcSEcCtD
Ribavirin—Myalgia—Prednisone—systemic scleroderma	2.14e-05	0.000217	CcSEcCtD
Ribavirin—Anxiety—Prednisone—systemic scleroderma	2.14e-05	0.000216	CcSEcCtD
Ribavirin—Alopecia—Methotrexate—systemic scleroderma	2.14e-05	0.000216	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	2.13e-05	0.000215	CcSEcCtD
Ribavirin—Discomfort—Prednisone—systemic scleroderma	2.12e-05	0.000214	CcSEcCtD
Ribavirin—Mental disorder—Methotrexate—systemic scleroderma	2.12e-05	0.000214	CcSEcCtD
Ribavirin—Erythema—Methotrexate—systemic scleroderma	2.11e-05	0.000213	CcSEcCtD
Ribavirin—Malnutrition—Methotrexate—systemic scleroderma	2.11e-05	0.000213	CcSEcCtD
Ribavirin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	2.08e-05	0.00021	CcSEcCtD
Ribavirin—Dysgeusia—Methotrexate—systemic scleroderma	2.06e-05	0.000208	CcSEcCtD
Ribavirin—Nausea—Lisinopril—systemic scleroderma	2.06e-05	0.000208	CcSEcCtD
Ribavirin—Anaphylactic shock—Prednisone—systemic scleroderma	2.06e-05	0.000208	CcSEcCtD
Ribavirin—Oedema—Prednisone—systemic scleroderma	2.06e-05	0.000208	CcSEcCtD
Ribavirin—Back pain—Methotrexate—systemic scleroderma	2.04e-05	0.000206	CcSEcCtD
Ribavirin—Shock—Prednisone—systemic scleroderma	2.02e-05	0.000205	CcSEcCtD
Ribavirin—Nervous system disorder—Prednisone—systemic scleroderma	2.02e-05	0.000204	CcSEcCtD
Ribavirin—Tachycardia—Prednisone—systemic scleroderma	2.01e-05	0.000203	CcSEcCtD
Ribavirin—Dizziness—Mycophenolate mofetil—systemic scleroderma	2.01e-05	0.000203	CcSEcCtD
Ribavirin—Skin disorder—Prednisone—systemic scleroderma	2e-05	0.000202	CcSEcCtD
Ribavirin—Hyperhidrosis—Prednisone—systemic scleroderma	1.99e-05	0.000201	CcSEcCtD
Ribavirin—Vision blurred—Methotrexate—systemic scleroderma	1.98e-05	0.000201	CcSEcCtD
Ribavirin—Anorexia—Prednisone—systemic scleroderma	1.96e-05	0.000198	CcSEcCtD
Ribavirin—Ill-defined disorder—Methotrexate—systemic scleroderma	1.95e-05	0.000198	CcSEcCtD
Ribavirin—Anaemia—Methotrexate—systemic scleroderma	1.95e-05	0.000197	CcSEcCtD
Ribavirin—Vomiting—Mycophenolate mofetil—systemic scleroderma	1.93e-05	0.000195	CcSEcCtD
Ribavirin—Rash—Mycophenolate mofetil—systemic scleroderma	1.91e-05	0.000193	CcSEcCtD
Ribavirin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.91e-05	0.000193	CcSEcCtD
Ribavirin—Headache—Mycophenolate mofetil—systemic scleroderma	1.9e-05	0.000192	CcSEcCtD
Ribavirin—Malaise—Methotrexate—systemic scleroderma	1.9e-05	0.000192	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—systemic scleroderma	1.89e-05	0.000191	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—systemic scleroderma	1.88e-05	0.000191	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	1.87e-05	0.000189	CcSEcCtD
Ribavirin—Insomnia—Prednisone—systemic scleroderma	1.86e-05	0.000188	CcSEcCtD
Ribavirin—Paraesthesia—Prednisone—systemic scleroderma	1.85e-05	0.000187	CcSEcCtD
Ribavirin—Cough—Methotrexate—systemic scleroderma	1.84e-05	0.000186	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—systemic scleroderma	1.82e-05	0.000184	CcSEcCtD
Ribavirin—Dyspepsia—Prednisone—systemic scleroderma	1.81e-05	0.000183	CcSEcCtD
Ribavirin—Nausea—Mycophenolate mofetil—systemic scleroderma	1.8e-05	0.000182	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—systemic scleroderma	1.79e-05	0.000181	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—systemic scleroderma	1.79e-05	0.000181	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—systemic scleroderma	1.79e-05	0.000181	CcSEcCtD
Ribavirin—Decreased appetite—Prednisone—systemic scleroderma	1.79e-05	0.000181	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	1.78e-05	0.00018	CcSEcCtD
Ribavirin—Fatigue—Prednisone—systemic scleroderma	1.77e-05	0.000179	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—systemic scleroderma	1.77e-05	0.000179	CcSEcCtD
Ribavirin—Constipation—Prednisone—systemic scleroderma	1.76e-05	0.000178	CcSEcCtD
Ribavirin—Confusional state—Methotrexate—systemic scleroderma	1.73e-05	0.000175	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—systemic scleroderma	1.72e-05	0.000174	CcSEcCtD
Ribavirin—Feeling abnormal—Prednisone—systemic scleroderma	1.69e-05	0.000171	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—systemic scleroderma	1.69e-05	0.00017	CcSEcCtD
Ribavirin—Thrombocytopenia—Methotrexate—systemic scleroderma	1.68e-05	0.00017	CcSEcCtD
Ribavirin—Gastrointestinal pain—Prednisone—systemic scleroderma	1.68e-05	0.00017	CcSEcCtD
Ribavirin—Skin disorder—Methotrexate—systemic scleroderma	1.67e-05	0.000169	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—systemic scleroderma	1.66e-05	0.000168	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—systemic scleroderma	1.64e-05	0.000166	CcSEcCtD
Ribavirin—Urticaria—Prednisone—systemic scleroderma	1.63e-05	0.000165	CcSEcCtD
Ribavirin—Body temperature increased—Prednisone—systemic scleroderma	1.63e-05	0.000164	CcSEcCtD
Ribavirin—Abdominal pain—Prednisone—systemic scleroderma	1.63e-05	0.000164	CcSEcCtD
Ribavirin—Hypotension—Methotrexate—systemic scleroderma	1.61e-05	0.000162	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	1.57e-05	0.000158	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—systemic scleroderma	1.55e-05	0.000157	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—systemic scleroderma	1.54e-05	0.000156	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—systemic scleroderma	1.53e-05	0.000155	CcSEcCtD
Ribavirin—Somnolence—Methotrexate—systemic scleroderma	1.53e-05	0.000154	CcSEcCtD
Ribavirin—Hypersensitivity—Prednisone—systemic scleroderma	1.51e-05	0.000153	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—systemic scleroderma	1.51e-05	0.000153	CcSEcCtD
Ribavirin—Decreased appetite—Methotrexate—systemic scleroderma	1.49e-05	0.000151	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	1.48e-05	0.00015	CcSEcCtD
Ribavirin—Fatigue—Methotrexate—systemic scleroderma	1.48e-05	0.00015	CcSEcCtD
Ribavirin—Asthenia—Prednisone—systemic scleroderma	1.48e-05	0.000149	CcSEcCtD
Ribavirin—Pain—Methotrexate—systemic scleroderma	1.47e-05	0.000149	CcSEcCtD
Ribavirin—Pruritus—Prednisone—systemic scleroderma	1.45e-05	0.000147	CcSEcCtD
Ribavirin—Feeling abnormal—Methotrexate—systemic scleroderma	1.42e-05	0.000143	CcSEcCtD
Ribavirin—Diarrhoea—Prednisone—systemic scleroderma	1.41e-05	0.000142	CcSEcCtD
Ribavirin—Gastrointestinal pain—Methotrexate—systemic scleroderma	1.41e-05	0.000142	CcSEcCtD
Ribavirin—Urticaria—Methotrexate—systemic scleroderma	1.37e-05	0.000138	CcSEcCtD
Ribavirin—Dizziness—Prednisone—systemic scleroderma	1.36e-05	0.000137	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—systemic scleroderma	1.36e-05	0.000137	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—systemic scleroderma	1.36e-05	0.000137	CcSEcCtD
Ribavirin—Vomiting—Prednisone—systemic scleroderma	1.31e-05	0.000132	CcSEcCtD
Ribavirin—Rash—Prednisone—systemic scleroderma	1.3e-05	0.000131	CcSEcCtD
Ribavirin—Dermatitis—Prednisone—systemic scleroderma	1.3e-05	0.000131	CcSEcCtD
Ribavirin—Headache—Prednisone—systemic scleroderma	1.29e-05	0.00013	CcSEcCtD
Ribavirin—Hypersensitivity—Methotrexate—systemic scleroderma	1.27e-05	0.000128	CcSEcCtD
Ribavirin—Asthenia—Methotrexate—systemic scleroderma	1.23e-05	0.000125	CcSEcCtD
Ribavirin—Nausea—Prednisone—systemic scleroderma	1.22e-05	0.000123	CcSEcCtD
Ribavirin—Pruritus—Methotrexate—systemic scleroderma	1.22e-05	0.000123	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—systemic scleroderma	1.18e-05	0.000119	CcSEcCtD
Ribavirin—Dizziness—Methotrexate—systemic scleroderma	1.14e-05	0.000115	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—systemic scleroderma	1.09e-05	0.00011	CcSEcCtD
Ribavirin—Rash—Methotrexate—systemic scleroderma	1.08e-05	0.00011	CcSEcCtD
Ribavirin—Dermatitis—Methotrexate—systemic scleroderma	1.08e-05	0.000109	CcSEcCtD
Ribavirin—Headache—Methotrexate—systemic scleroderma	1.08e-05	0.000109	CcSEcCtD
Ribavirin—Nausea—Methotrexate—systemic scleroderma	1.02e-05	0.000103	CcSEcCtD
